App and Body Fat Scale in the Management of Overweight Patients
Key facts
- Where
- Beijing, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Source: NCT05866107, who can take part
Where in China
- Beijing Anding HospitalBeijing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Capital Medical University
- Trial code
- NCT05866107
- Record updated
- 5 June 2025
- Original description
This study tests whether using a health app (Huawei Health) and a smart body fat scale can help overweight patients with schizophrenia or bipolar disorder lose weight and stay engaged in their health.Read full original descriptionShow less
Effectiveness and Feasibility of Self-Monitoring for Weight Management in Individuals With Mental Disorders Using Digital Intervention ("SWIM" Trial)
This study tests whether using a health app (Huawei Health) and a smart body fat scale can help overweight patients with schizophrenia or bipolar disorder lose weight and stay engaged in their health.
What We're Testing:
1. Patients who use the app and scale for 4 months (Group 1) will lose more weight than those who use them for 2 months (Group 2). 2. Patients who track their weight, diet, and exercise regularly (≥3 times/week) will lose more weight than those who don't. 3. Seeing weight loss results may motivate patients to keep using the app and scale.
How It Works:
Patients weigh themselves weekly with the scale (auto-syncs to the app) and upload dietary log in Huawei Health app. The app will gives personalized diet/exercise tips and tracks progress. Doctors and nutritionists provide extra support through messages.
Goal:
To see if this digital tool + professional support combo works better for long-term weight management.
Inclusion: Age 18-60 years old, no gender restriction; According to ICD-10 to diagnose bipolar disorder or schizophrenia, the researcher judges that the patient is currently in remission, or the condition is stable and can cooperate with the research; Currently using at least one antipsychotic or mood stabilizer (e.g. lithium, magnesium valproate, sodium valproate, lamotrigine); Currently overweight or obese (body mass index ≥ 24kg/m2) and willing to use health app and smart scales to lose weight; The education level of primary school or above, able to understand the content of the scale, and be able to use smart phone proficiently; Understand and voluntarily participate in this study, and sign the informed consent form.
Exclusion: Plan to lose weight by other methods during the study period (such as dieting, inducing vomiting, taking diet pills, surgery); Other secondary obesity (such as hypothyroidism, Cushing's syndrome, hypothalamic obesity, etc.); Self-reported cardiac discomfort or chest pain during activity or at rest; There is a serious medical condition, and the researchers believe that there may be safety risks when participating in sports; There are problems that may affect compliance with the protocol (eg, end-stage disease, planning to move travel to the field, history of substance abuse, other uncontrolled or untreated medical conditions); Any other conditions deemed inappropriate by the investigator; Participants include approximately 50% with schizophrenia and 50% with bipolar disorder, distributed across all clusters; Self-reported weight loss ≥ 7% in the past 6 months; Weight over 150 kg; Currently pregnant, lactating, < 6 months postpartum or planning to become pregnant during the study period; Be unable to walk 30 minutes without stopping.